Brief: ASBISc Enterprises To Buy 16% Stake In Cyprus-Based Promed Bioscience
Nov 9 (Reuters) - ASBISc Enterprises PLC ASBP.WA :
* SIGNS DEAL ON PURCHASE OF 16% STAKE IN PROMED BIOSCIENCE,
CYPRUS
* DEAL PRICE SET AT EUR 0.8 MILLION
* PROMED BIOSCIENCE IS A BIOTECH COMPANY FOUNDED IN 2017
WHICH
PRODUCES BIOMATERIALS ON BASE OF COLAGEN
* COMPANY USED OWN FUNDING TO SECURE PURCHASE OF SAID STAKE
Source text for Eikon: ID:nEM7nmCYza
Further company coverage: ASBP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ASBISc Enterprises
See all newsBrief: ASBISc Estimated Consolidated May Revenue At About $604 Mln
Brief: ASBISc Enterprises Unit ASBIS Middle East Signs Distribution Deal With Apple
Brief: ASBISc Enterprises Sees April Revenue Up At $444 Million
Brief: ASBISc Enterprises Q1 Net Profit $36.5 Mln
Brief: ASBISc Enterprises Prelim. March Revenue At About $462 Million